glp-1 news today obesity drug updates ADA 2026 confirmed what many of us have been anticipating for years. We're entering a new era of medicine: triple agonists, oral GLP-1s, monthly injections, and therapies targeting obesity, diabetes, and Pharma Giants Bet on Next-Generation

Exercise, especially resistance training, is strongly encouraged while on GLP-1 medications

[1] [5] These gastrointestinal effects typically diminish over time as the body adjusts to the medication

Consequently, businesses should rethink their operations and revenue streams to offer value that aligns with this new consumer ethos. Market research thus far has indicated that GLP-1 drugs may impact consumer spending on food and beverages namely, on candy and sugary snacks and drinks in shopping regularity, basket size and product choices as these medications affect eating habits in areas such as frequency, portion size and taste preferences

Frontiers in Drug Discovery

Data also shows how rapidly these flagship products have come to fuel the majority of revenue for both companies, highlighting the revenue concentration characteristic of financialized business models

Trulicity may increase the chance of food getting into your lungs during surgery or other procedures